Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia.

作者: J Liu , Y Xu , H Zhang , X Gao , H Fan

DOI: 10.1038/JHH.2014.22

关键词:

摘要: Hyperhomocysteinemia (HHcy) is an independent risk factor for coronary artery disease. Chronic HHcy induces endothelial injury, and homocysteine (Hcy) inhibits insulin sensitivity by inducing endoplasmic reticulum stress in adipose tissue. However, the combined effects of chronic hypertension on function have still remained unclear. Fifty-one patients with essential (HT) were recruited, divided into nHT group (without HHcy) H-type HT (with HHcy). Forty healthy subjects enrolled as controls. We assessed flow velocity reserve (CFVR). Hcy levels significantly higher (15.60±6.58 vs 13.08±4.13 μmol l−1, P<0.05), whereas CFVR values lower than control (2.88±0.70 3.23±0.54, P<0.05). negatively correlated value (r=−0.578, P<0.01, 95% confidence interval −0.085 to −0.046). The homeostasis model assessment-insulin resistance (3.92±2.16 2.72±1.50, P<0.05) , (2.31±0.31 3.25±0.62, P<0.01). Coronary may be impaired hypertensive HHcy, induced contribute this damage.

参考文章(32)
Cheng Ji, Neil Kaplowitz, Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury World Journal of Gastroenterology. ,vol. 10, pp. 1699- 1708 ,(2004) , 10.3748/WJG.V10.I12.1699
Shahzad Faizul Haque, Vibhanshu Gupta, Anwar Salamat Khan, Sandeep Sachdeva, Endothelial dysfunction and inflammation in different stages of essential hypertension. Saudi Journal of Kidney Diseases and Transplantation. ,vol. 22, pp. 97- 103 ,(2011)
Ting-Ting Yan, Qian Li, Xuan-Hong Zhang, Wei-Kang Wu, Juan Sun, Lin Li, Quan Zhang, Hong-Mei Tan, Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling. Clinical and Experimental Pharmacology and Physiology. ,vol. 37, pp. 1071- 1077 ,(2010) , 10.1111/J.1440-1681.2010.05438.X
M. Emoto, H. Kanda, T. Shoji, T. Kawagishi, M. Komatsu, K. Mori, H. Tahara, E. Ishimura, M. Inaba, Y. Okuno, Y. Nishizawa, Impact of Insulin Resistance and Nephropathy on Homocysteine in Type 2 Diabetes Diabetes Care. ,vol. 24, pp. 533- 538 ,(2001) , 10.2337/DIACARE.24.3.533
Jamal Golbahar, Mohammad Amin Aminzadeh, Salah Eddin Kassab, Golamhossein Rangbar Omrani, Hyperhomocysteinemia induces insulin resistance in male Sprague–Dawley rats Diabetes Research and Clinical Practice. ,vol. 76, pp. 1- 5 ,(2007) , 10.1016/J.DIABRES.2006.07.026
Cullen M. Taniguchi, Brice Emanuelli, C. Ronald Kahn, Critical nodes in signalling pathways: Insights into insulin action Nature Reviews Molecular Cell Biology. ,vol. 7, pp. 85- 96 ,(2006) , 10.1038/NRM1837
Dongjuan Wang, Haichang Wang, Peng Luo, Andrew Hwang, Dongdong Sun, Yabin Wang, Zheng Zhang, Nan Liu, Shenxu Wang, Chengxiang Li, Feng Cao, Effects of ghrelin on homocysteine-induced dysfunction and inflammatory response in rat cardiac microvascular endothelial cells Cell Biology International. ,vol. 36, pp. 511- 517 ,(2012) , 10.1042/CBI20110235
Vikas Veeranna, Sandip K Zalawadiya, Ashutosh Niraj, Jyotiranjan Pradhan, Brian Ference, Robert C Burack, Sony Jacob, Luis Afonso, None, Homocysteine and Reclassification of Cardiovascular Disease Risk Journal of the American College of Cardiology. ,vol. 58, pp. 1025- 1033 ,(2011) , 10.1016/J.JACC.2011.05.028
M. Buysschaert, A. S. Dramais, P. E. Wallemacq, M. P. Hermans, Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care. ,vol. 23, pp. 1816- 1822 ,(2000) , 10.2337/DIACARE.23.12.1816
S Najib, V Sanchez-Margalet, Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. Journal of Molecular Endocrinology. ,vol. 27, pp. 85- 91 ,(2001) , 10.1677/JME.0.0270085